Concepedia

Camilla Zecchetto

CZ

Statistics

Publications

16

Citations

1K

H-Index

13

Active since

2017

Affiliations

University of Verona(Current)

Azienda Ospedaliera Universitaria Integrata Verona

Istituto Oncologico Veneto

Ospedale Santa Chiara

Institut Gustave Roussy

Camilla Zecchetto is an author at University of Verona specializing in medicine, oncology, and pancreatic cancer.

ORCID

Publications per year

2017–2024

16

Publications

16

Clinicogenomic Analysis of <i>FGFR2</i> -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib

Ian M. Silverman, Antoine Hollebecque, Luc Friboulet et al. · Cancer Discovery · 2020 · 284 citations · Full text

, , +17

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

Davide Melisi, Do‐Youn Oh, Antoine Hollebecque et al. · Journal for ImmunoTherapy of Cancer · 2021 · 196 citations · Full text

, , +17

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Laura Maggino, Giuseppe Malleo, Giovanni Marchegiani et al. · JAMA Surgery · 2019 · 141 citations · Full text

, , +12

Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer

Raffaela Santoro, Marco Zanotto, Francesca Simionato et al. · Molecular Cancer Therapeutics · 2019 · 62 citations · Full text

, , +17

A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma

Geny Piro, Francesca Simionato, Carmine Carbone et al. · OncoImmunology · 2017 · 53 citations · Full text

, , +17

1–5 of 16